Sarcoma
Why trials studying Sarcoma stopped, in this sample of ClinicalTrials.gov.
18 stopped trials with a clear reason; 100% ended for non-scientific reasons.
| Reason | Trials | Share |
|---|---|---|
| funding business | 9 | 50% |
| slow accrual | 5 | 28% |
| logistics pi | 3 | 17% |
| manufacturing supply | 1 | 6% |
Trials
- Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers
NCT04553692 · TERMINATED · funding business
“Study terminated due strategic corporate pivot to focus on auto-immune indications” - Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR Trial
NCT04190433 · WITHDRAWN · slow accrual
“Administratively closed due to low/no accrual” - Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease
NCT01125449 · WITHDRAWN · manufacturing supply
“Awaiting response from FDA as to status of parenteral ascorbic acid manufactured by Bioniche (Ireland).” - Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors
NCT03604783 · TERMINATED · funding business
“Sponsor's decision to terminate further development of the program.” - A Phase 3, Randomized, Double-blind, Placebo-controlled Study For Subjects With Locally-advanced Unresectable or Metastatic Synovial Sarcoma (V943-003, IMDZ-04-1702)
NCT03520959 · TERMINATED · funding business
“Study was terminated due to sponsor's decision.” - A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide
NCT03495921 · TERMINATED · funding business
“Slow accrual and as a result, a strategic business decision was made to terminate enrollment.” - REVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor Malignancies
NCT03435640 · TERMINATED · funding business
“Based on the overall results from the Phase 1 part of the study the sponsor decided to end the study. The decision was not due to safety reasons.” - A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)
NCT02576665 · TERMINATED · funding business
“Sponsor decision” - National Swiss Sarcoma Cohort Study
NCT02775799 · TERMINATED · logistics pi
“Principal Investigator has left the Institution” - ODSH + ICE Chemotherapy in Pediatric Solid Tumors
NCT02164097 · TERMINATED · slow accrual
“low accrual” - Cryoablation, Radiofrequency Ablation, or Microwave Ablation in Treating Patients With Metastatic Sarcoma Stable on Chemotherapy
NCT01986829 · TERMINATED · slow accrual
“Slow accrual” - A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection
NCT02005614 · TERMINATED · slow accrual
“Unable to recruit patients.” - Development of a Biomarker Directed Strategy to Ameliorate Common Toxicities From Conventional Chemotherapy
NCT01921998 · SUSPENDED · logistics pi
“Trial has been suspended due to lack of resource and staff” - Sorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Removed by Surgery
NCT00880542 · TERMINATED · funding business
“The study lost funding.” - Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma
NCT00334984 · WITHDRAWN · funding business
“Withdrawn due to inability to reach an acceptable agreement with industry sponsor” - G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders
NCT00253552 · TERMINATED · logistics pi
“Terminated at request of PI as study was outdated.” - Combination Chemotherapy and Dexrazoxane Followed by Surgery and Radiation Therapy in Treating Patients With Advanced Soft Tissue Sarcoma or Recurrent Bone Sarcoma
NCT00544778 · TERMINATED · funding business
“The study was terminated prematurely due to withdrawal of support by the sponsor.” - Cryosurgery in Treating Patients With Soft Tissue Sarcoma
NCT00002863 · TERMINATED · slow accrual
“Insufficient Accrual”
Reasons are labeled automatically and are unverified. See the methodology. This is research information, not medical advice. Search the full database.